Crinetics Pharmaceuticals (CRNX) Earnings (2017 - 2026)
Crinetics Pharmaceuticals (CRNX) earnings from Jun 30, 2017 to Mar 31, 2026. The TTM Crinetics Pharmaceuticals (CRNX) earnings is -$496M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Crinetics Pharmaceuticals (CRNX) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +51.22% |
| 3 Years TTM | +41.48% |
| 5 Years TTM | +44.30% |
| All Time TTM | +59.35% |
Annual Earnings change of Crinetics Pharmaceuticals (CRNX)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$128M | -72.53% |
| 2025 | -$465M | +55.93% |
| 2024 | -$298M | +39.10% |
| 2023 | -$215M | +30.87% |
| 2022 | -$164M | +52.29% |
| 2021 | -$108M | +45.83% |
| 2020 | -$74M | +46.39% |
| 2019 | -$50M | +85.98% |
| 2018 | -$27M | +195.96% |
| 2017 | -$9.16M | +52.16% |
| 2016 | -$6.02M | N/A |
Comparison Crinetics Pharmaceuticals (CRNX) five years earnings CAGR with competitors
Crinetics Pharmaceuticals (CRNX) five years earnings CAGR is 44.30%.